Obesity as Chronic Disease Building a Follow-up Model Like HTNA1c Abstract Obesity is increasingly recognized as a chronic, relapsing, multifactorial disease that requires long term clinical management rather than episodic intervention. Its pathophysiology involves complex interactions among genetic predisposition, neuroendocrine regulation, metabolic adaptation, environmental
Tag: obesity
Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs
Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a transformative class of medications in the management of type 2 diabetes, demonstrating an approximate 14 percent reduction in major adverse cardiovascular events. Initially developed
The Tirzepatide Revolution: Is Dual Agonism the End of Single-Pathway Therapy?
The Tirzepatide Revolution: Is Dual Agonism the End of Single-Pathway Therapy? Abstract The development of tirzepatide, a first in class dual glucose dependent insulinotropic polypeptide and glucagon like peptide 1 receptor agonist, represents a potentially transformative advance in the management of type 2 diabetes and obesity. By simultaneously targeting
Obesity Medications: Should Family Practice Physicians Prescribe More Aggressively?
Obesity Medications Should Family Practice Physicians Prescribe More Aggressively Check out our extensive video library (see channel for our latest videos) Abstract Obesity has escalated into a global public health crisis, affecting more than 650 million adults and contributing markedly to morbidity, mortality, and healthcare
Psychiatry’s Role in the Obesity Epidemic
Pediatric Obesity: Should We Prescribe GLP-1 Agonists for Adolescents?
Breaking Free: How Mounjaro Helps Smokers Quit Without Nicotine Patches
Breaking Free How Mounjaro Helps Smokers Quit Without Nicotine Patches Check back later for a possible video summary. Videos are created for most articles. Introduction Breaking Free: How Mounjaro Helps Smokers Quit Without Nicotine Patches In 2021, almost 46 million adults in the United States reported using nicotine products, and research on the
Intelligence Of Offspring Related To Parental Obesity
Intelligence Of Offspring Related To Parental Obesity Overview The impact of maternal obesity on childhood cognitive development remains uncertain. Previous research has often lacked proper adjustments for key confounding factors, and preterm children, who represent a distinct developmental group, have been underexplored. This study aimed to investigate whether maternal prepregnancy body
Artificial Sweeteners And Health
Artificial Sweeteners And Health Carbohydrates are a significant energy source, making up forty (40%) to eighty (80%) of our daily consumption. They exist in two forms: free sugars and nonfree sugars. Nonfree sugars are found naturally in foods like fruits, vegetables, grains, and dairy. In contrast, free sugars are added during
Weight Maintenance Success Of Antiobesity Medications After 1 Year
Weight Maintenance Success Of Antiobesity Medications After 1 Year Overview The high cost of novel glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often limits their accessibility, creating significant barriers to care. This study explored the effectiveness of older, generic anti-obesity medications (AOMs) in sustaining weight loss after a year of GLP-1
